Ssv Pharma Profile
Key Indicators
- Authorised Capital ₹ 22.50 Cr
as on 13-12-2024
- Paid Up Capital ₹ 22.30 Cr
as on 13-12-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 74.00 Cr
as on 13-12-2024
- Revenue 118.71%
(FY 2023)
- Profit -84.27%
(FY 2023)
- Ebitda -21.88%
(FY 2023)
- Net Worth -22.75%
(FY 2023)
- Total Assets -0.16%
(FY 2023)
About Ssv Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 22.50 Cr and a paid-up capital of Rs 22.30 Cr.
The company currently has active open charges totaling ₹74.00 Cr.
Gorantla Rao, Gorantla Subhashini, Sridevi Talluri, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24305TG2016PTC111579
- Company No.
111579
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Aug 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ssv Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gorantla Rao  | Director | 22-Aug-2016 | Current |
| Gorantla Subhashini | Director | 22-Aug-2016 | Current |
| Sridevi Talluri | Director | 02-Dec-2020 | Current |
| Talluri Rao | Director | 21-Feb-2022 | Current |
| Sai Gorantla | Director | 22-Aug-2016 | Current |
Financial Performance of Ssv Pharma.
Ssv Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 118.71% increase. The company also saw a substantial fall in profitability, with a 84.27% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ssv Pharma?
In 2023, Ssv Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ssv Sai Infrastructure LlpActive 7 years 7 monthsGorantla Rao and Gorantla Subhashini are mutual person
- Ssv Ginners Private LimitedActive 13 years 8 months
Gorantla Rao and Gorantla Subhashini are mutual person
- Ssv Spinners Private LimitedActive 13 years 10 months
Gorantla Rao and Gorantla Subhashini are mutual person
- Ssv Chit Fund Private LimitedActive 27 years 3 months
Gorantla Rao and Gorantla Subhashini are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 May 2020 | ₹74.00 Cr | Open |
How Many Employees Work at Ssv Pharma?
Ssv Pharma has a workforce of 132 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ssv Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ssv Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
